IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5–79 years). Se...
Saved in:
| Published in | Nature communications Vol. 12; no. 1; pp. 2133 - 9 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
09.04.2021
Nature Publishing Group Nature Portfolio |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5–79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6
+
TNF
-
IL-1β
+
monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4
+
T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity.
Our understanding of the immune response to SARS-CoV-2 infection is still incomplete. Here, the authors find that IL-33, produced during immune recall potentially by CD14
+
monocytes, correlates with CD4
+
T cell activation, anti-SARS-CoV-2 antibody titer, and disease severity in a cohort of convalescent individuals professionally exposed to the virus. |
|---|---|
| AbstractList | Our understanding of the immune response to SARS-CoV-2 infection is still incomplete. Here, the authors find that IL-33, produced during immune recall potentially by CD14+ monocytes, correlates with CD4+ T cell activation, anti-SARS-CoV-2 antibody titer, and disease severity in a cohort of convalescent individuals professionally exposed to the virus. Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5–79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6 + TNF - IL-1β + monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4 + T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity. Our understanding of the immune response to SARS-CoV-2 infection is still incomplete. Here, the authors find that IL-33, produced during immune recall potentially by CD14 + monocytes, correlates with CD4 + T cell activation, anti-SARS-CoV-2 antibody titer, and disease severity in a cohort of convalescent individuals professionally exposed to the virus. Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5-79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6 TNF IL-1β monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4 T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity. Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5-79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6+TNF-IL-1β+ monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4+ T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity.Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5-79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6+TNF-IL-1β+ monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4+ T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity. Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5–79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6+TNF-IL-1β+ monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4+ T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity.Our understanding of the immune response to SARS-CoV-2 infection is still incomplete. Here, the authors find that IL-33, produced during immune recall potentially by CD14+ monocytes, correlates with CD4+ T cell activation, anti-SARS-CoV-2 antibody titer, and disease severity in a cohort of convalescent individuals professionally exposed to the virus. Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate seroprevalence and immune responses in subjects professionally exposed to SARS-CoV-2 and their family members (155 individuals; ages 5–79 years). Seropositivity for SARS-CoV-2 Spike glycoprotein aligns with PCR results that confirm the previous infection. Anti-Spike IgG/IgM titers remain high 60 days post-infection and do not strongly associate with symptoms, except for fever. We analyze PBMCs from a subset of seropositive and seronegative adults. TLR7 agonist-activation reveals an increased population of IL-6 + TNF - IL-1β + monocytes, while SARS-CoV-2 peptide stimulation elicits IL-33, IL-6, IFNa2, and IL-23 expression in seropositive individuals. IL-33 correlates with CD4 + T cell activation in PBMCs from convalescent subjects and is likely due to T cell-mediated effects on IL-33-producing cells. IL-33 is associated with pulmonary infection and chronic diseases like asthma and COPD, but its role in COVID-19 is unknown. Analysis of published scRNAseq data of bronchoalveolar lavage fluid (BALF) from patients with mild to severe COVID-19 reveals a population of IL-33-producing cells that increases with the disease. Together these findings show that IL-33 production is linked to SARS-CoV-2 infection and warrant further investigation of IL-33 in COVID-19 pathogenesis and immunity. |
| ArticleNumber | 2133 |
| Author | Steinmann, Daniel Pearce, Edward J. Hofmann, Maike Apostolova, Petya Sanin, David E. Waller, Cornelius F. Krohn-Grimberghe, Marvin Lampaki, Dimitrios Thimme, Robert Pearce, Erika L. Stanczak, Michal A. Nerz, Gabriele Mittler, Gerhard |
| Author_xml | – sequence: 1 givenname: Michal A. orcidid: 0000-0003-2563-7254 surname: Stanczak fullname: Stanczak, Michal A. organization: Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics – sequence: 2 givenname: David E. orcidid: 0000-0003-0188-7267 surname: Sanin fullname: Sanin, David E. organization: Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics – sequence: 3 givenname: Petya orcidid: 0000-0002-3856-5109 surname: Apostolova fullname: Apostolova, Petya organization: Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics – sequence: 4 givenname: Gabriele surname: Nerz fullname: Nerz, Gabriele organization: Proteomics, Max Planck Institute of Immunobiology and Epigenetics – sequence: 5 givenname: Dimitrios surname: Lampaki fullname: Lampaki, Dimitrios organization: Proteomics, Max Planck Institute of Immunobiology and Epigenetics – sequence: 6 givenname: Maike orcidid: 0000-0001-8410-8833 surname: Hofmann fullname: Hofmann, Maike organization: Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg – sequence: 7 givenname: Daniel surname: Steinmann fullname: Steinmann, Daniel organization: Occupational Medical Service, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg – sequence: 8 givenname: Marvin surname: Krohn-Grimberghe fullname: Krohn-Grimberghe, Marvin organization: Department of Cardiology and Angiology I, University Heart Center Freiburg – sequence: 9 givenname: Robert surname: Thimme fullname: Thimme, Robert organization: Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg – sequence: 10 givenname: Gerhard surname: Mittler fullname: Mittler, Gerhard organization: Proteomics, Max Planck Institute of Immunobiology and Epigenetics – sequence: 11 givenname: Cornelius F. orcidid: 0000-0002-5777-0212 surname: Waller fullname: Waller, Cornelius F. email: cornelius.waller@uniklinik-freiburg.de organization: Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg – sequence: 12 givenname: Edward J. surname: Pearce fullname: Pearce, Edward J. email: epearce7@jhmi.edu organization: Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, Faculty of Biology, University of Freiburg, The Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins – sequence: 13 givenname: Erika L. orcidid: 0000-0001-5592-5439 surname: Pearce fullname: Pearce, Erika L. email: epearce6@jhmi.edu organization: Department of Immunometabolism, Max Planck Institute of Immunobiology and Epigenetics, The Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33837219$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1vEzEQhi1UREvoH-CAVuLCxeCv3bUvSFXKR6RIlSj0ajne2dTRxg62k9B_j7dpoe2hPngsz_O-GnvmNTrywQNCbyn5SAmXn5KgomkxYRQzJoTC-xfohBFBMW0ZP3pwPkanKa1IWVxRKcQrdMy55C2j6gT52RxzXsGfTYSUXPCV81U5boJPUOVQXZ79uMTTcIVZZUOMMJgMqdq7fF0liGETkstu5_LNKJxeXM3OMVUF9TszQLLgc0l0hei2Zkhv0Mu-BDi9ixP06-uXn9PveH7xbTY9m2NbC5KxlJLzXhEwvLULA7YrESjwWsiFpU3P68aOOSWAgKTWNqQub6sJbZqetXyCZgffLpiV3kS3NvFGB-P07UWIS21idnYALZXivG1lrRgIVXemM1QQplTfs17aunh9Pnhttos1dOOTohkemT7OeHetl2GnJeH12IAJ-nBnEMPvLaSs1678zDAYD2GbNKspZYKVraDvn6CrsI2-fNVIEaGoIiP17mFF_0q5b2sB5AGwMaQUodfWZZNLe0uBbtCU6HGI9GGIdBkifTtEel-k7In03v1ZET-IUoH9EuL_sp9R_QX9atiC |
| CitedBy_id | crossref_primary_10_1183_23120541_00919_2023 crossref_primary_10_3390_biomedicines10112889 crossref_primary_10_3389_fimmu_2022_975914 crossref_primary_10_2147_JIR_S336404 crossref_primary_10_3389_fimmu_2022_864298 crossref_primary_10_3389_fmed_2021_749569 crossref_primary_10_1007_s10565_024_09976_0 crossref_primary_10_1016_j_cytogfr_2024_12_003 crossref_primary_10_3389_fimmu_2021_752380 crossref_primary_10_3390_ijms24119487 crossref_primary_10_1016_j_isci_2021_103478 crossref_primary_10_1002_jmv_28122 crossref_primary_10_3389_fimmu_2021_688879 crossref_primary_10_1155_2022_9534163 crossref_primary_10_3390_ijms23094894 crossref_primary_10_1080_21548331_2022_2088183 crossref_primary_10_1016_j_compbiomed_2022_106055 crossref_primary_10_1080_07853890_2021_1921252 crossref_primary_10_1186_s11658_022_00311_1 crossref_primary_10_1016_j_isci_2024_110117 crossref_primary_10_1183_23120541_00249_2023 crossref_primary_10_1002_eji_202249951 crossref_primary_10_3389_fimmu_2023_1170035 crossref_primary_10_3389_fimmu_2023_1170012 crossref_primary_10_3389_fimmu_2022_832394 crossref_primary_10_1097_CCM_0000000000005716 crossref_primary_10_1097_SHK_0000000000002114 crossref_primary_10_1002_jcb_30017 crossref_primary_10_1002_jmv_28751 crossref_primary_10_1016_j_omtn_2022_06_017 crossref_primary_10_3390_ijms232314532 crossref_primary_10_3389_fimmu_2021_601080 crossref_primary_10_1038_s41598_023_50035_1 crossref_primary_10_1111_imm_13404 crossref_primary_10_3390_life12111767 crossref_primary_10_1128_spectrum_00878_23 crossref_primary_10_3390_cells12232696 crossref_primary_10_3390_jcm10184110 crossref_primary_10_3389_fimmu_2021_743890 crossref_primary_10_3389_fimmu_2022_821730 crossref_primary_10_3390_biomedicines10030715 |
| Cites_doi | 10.1016/j.cell.2020.08.017 10.1038/s41591-020-0901-9 10.1038/s41591-020-0897-1 10.1038/s41591-020-0913-5 10.1056/NEJMoa2002032 10.1038/s41467-020-18450-4 10.1186/s12879-020-05681-5 10.1016/S2665-9913(20)30340-4 10.1186/s12931-020-01511-z 10.1038/s41586-020-2550-z 10.1038/s41591-020-1051-9 10.21105/joss.00861 10.1038/s41421-020-0168-9 10.1016/j.vaccine.2019.03.044 10.1002/cti2.1136 10.1126/science.1215418 10.1016/j.jaci.2017.07.051 10.1016/S2213-2600(20)30404-5 10.1038/s41590-020-0782-6 10.1016/S0140-6736(20)30183-5 10.1016/j.immuni.2020.11.017 10.1016/j.cell.2020.10.052 10.1016/j.cell.2019.05.031 10.1038/s41591-020-0819-2 10.1186/s13059-019-1874-1 10.1016/j.immuni.2015.06.006 10.4049/jimmunol.1701757 10.1158/0008-5472.CAN-13-2729 10.1128/JVI.01182-10 10.1038/s41586-020-2598-9 10.1038/358764a0 10.1126/sciadv.abe3024 10.1101/2020.12.18.20248331 10.1126/science.369.6508.1203-l |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
| DOI | 10.1038/s41467-021-22449-w |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Coronavirus Research Database ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection PML(ProQuest Medical Library) Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database CrossRef |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2041-1723 |
| EndPage | 9 |
| ExternalDocumentID | oai_doaj_org_article_89933778592e495dada140299ff2f8c5 PMC8035172 33837219 10_1038_s41467_021_22449_w |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AARCD AZQEC C1K COVID DWQXO FR3 GNUQQ H94 K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 SOI 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c540t-88833f90ea37cbaecd37ce1e3548bc16f356ca37c94e0e81cc60518450166f273 |
| IEDL.DBID | M48 |
| ISSN | 2041-1723 |
| IngestDate | Wed Aug 27 01:20:45 EDT 2025 Thu Aug 21 13:53:40 EDT 2025 Thu Jul 10 22:06:04 EDT 2025 Wed Aug 13 11:13:09 EDT 2025 Wed Feb 19 02:28:49 EST 2025 Thu Apr 24 22:51:37 EDT 2025 Tue Jul 01 04:17:22 EDT 2025 Fri Feb 21 02:39:00 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-88833f90ea37cbaecd37ce1e3548bc16f356ca37c94e0e81cc60518450166f273 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-8410-8833 0000-0002-3856-5109 0000-0001-5592-5439 0000-0003-2563-7254 0000-0002-5777-0212 0000-0003-0188-7267 |
| OpenAccessLink | https://www.nature.com/articles/s41467-021-22449-w |
| PMID | 33837219 |
| PQID | 2510491902 |
| PQPubID | 546298 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_89933778592e495dada140299ff2f8c5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8035172 proquest_miscellaneous_2511242112 proquest_journals_2510491902 pubmed_primary_33837219 crossref_citationtrail_10_1038_s41467_021_22449_w crossref_primary_10_1038_s41467_021_22449_w springer_journals_10_1038_s41467_021_22449_w |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-04-09 |
| PublicationDateYYYYMMDD | 2021-04-09 |
| PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-09 day: 09 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Nature communications |
| PublicationTitleAbbrev | Nat Commun |
| PublicationTitleAlternate | Nat Commun |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Braun (CR4) 2020; 587 Long (CR1) 2020; 26 CR17 CR14 CR11 Sekine (CR3) 2020; 183 Guan (CR25) 2020; 382 Gong (CR23) 2020; 20 Bonilla (CR28) 2012; 335 Le Bert (CR5) 2020; 584 Bernardes (CR19) 2020; 53 Liao (CR20) 2020; 26 Huang (CR9) 2020; 395 Hafemeister, Satija (CR33) 2019; 20 Hou (CR13) 2020; 9 Werder (CR24) 2018; 141 Thevarajan (CR16) 2020; 26 Villarreal (CR27) 2014; 74 Burke (CR8) 2020; 21 Molofsky, Savage, Locksley (CR22) 2015; 42 Peng (CR6) 2020; 21 Leisman (CR10) 2020; 8 Del Valle (CR7) 2020; 26 Zohar (CR15) 2020; 183 McInnes, Healy, Saul, Großberger (CR34) 2018; 3 Wen (CR18) 2020; 6 Sarkar (CR30) 2019; 37 Huang (CR2) 2020; 11 McLaren (CR29) 2019; 202 Kayamuro (CR31) 2010; 84 Amanat (CR12) 2020; 26 Chicz (CR21) 1992; 358 Zizzo, Cohen (CR26) 2020; 2 Stuart (CR32) 2019; 177 22449_CR11 DE Leisman (22449_CR10) 2020; 8 I Thevarajan (22449_CR16) 2020; 26 N Le Bert (22449_CR5) 2020; 584 S Sarkar (22449_CR30) 2019; 37 Y Peng (22449_CR6) 2020; 21 T Zohar (22449_CR15) 2020; 183 C Hafemeister (22449_CR33) 2019; 20 L McInnes (22449_CR34) 2018; 3 W-J Guan (22449_CR25) 2020; 382 M Liao (22449_CR20) 2020; 26 C Huang (22449_CR9) 2020; 395 22449_CR14 22449_CR17 DM Del Valle (22449_CR7) 2020; 26 H Hou (22449_CR13) 2020; 9 J Gong (22449_CR23) 2020; 20 WV Bonilla (22449_CR28) 2012; 335 DO Villarreal (22449_CR27) 2014; 74 H Burke (22449_CR8) 2020; 21 T Sekine (22449_CR3) 2020; 183 W Wen (22449_CR18) 2020; 6 G Zizzo (22449_CR26) 2020; 2 J Braun (22449_CR4) 2020; 587 AT Huang (22449_CR2) 2020; 11 JP Bernardes (22449_CR19) 2020; 53 H Kayamuro (22449_CR31) 2010; 84 RM Chicz (22449_CR21) 1992; 358 F Amanat (22449_CR12) 2020; 26 Q-X Long (22449_CR1) 2020; 26 AB Molofsky (22449_CR22) 2015; 42 RB Werder (22449_CR24) 2018; 141 T Stuart (22449_CR32) 2019; 177 JE McLaren (22449_CR29) 2019; 202 |
| References_xml | – volume: 183 start-page: 158 year: 2020 end-page: 168.e14 ident: CR3 article-title: Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 publication-title: Cell doi: 10.1016/j.cell.2020.08.017 – volume: 26 start-page: 842 year: 2020 end-page: 844 ident: CR20 article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-0901-9 – volume: 26 start-page: 845 year: 2020 end-page: 848 ident: CR1 article-title: Antibody responses to SARS-CoV-2 in patients with COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-0897-1 – volume: 26 start-page: 1033 year: 2020 end-page: 1036 ident: CR12 article-title: A serological assay to detect SARS-CoV-2 seroconversion in humans publication-title: Nat. Med. doi: 10.1038/s41591-020-0913-5 – volume: 382 start-page: 1708 year: 2020 end-page: 1720 ident: CR25 article-title: Clinical characteristics of Coronavirus Disease 2019 in China publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2002032 – volume: 11 year: 2020 ident: CR2 article-title: A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity publication-title: Nat. Commun. doi: 10.1038/s41467-020-18450-4 – ident: CR14 – volume: 20 year: 2020 ident: CR23 article-title: Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study publication-title: BMC Infect. Dis. doi: 10.1186/s12879-020-05681-5 – volume: 2 start-page: e779 year: 2020 end-page: e790 ident: CR26 article-title: Imperfect storm: is interleukin-33 the Achilles heel of COVID-19? publication-title: Lancet Rheumatol. doi: 10.1016/S2665-9913(20)30340-4 – volume: 21 start-page: 245 year: 2020 ident: CR8 article-title: Inflammatory phenotyping predicts clinical outcome in COVID-19 publication-title: Respir. Res. doi: 10.1186/s12931-020-01511-z – volume: 584 start-page: 457 year: 2020 end-page: 462 ident: CR5 article-title: SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls publication-title: Nature doi: 10.1038/s41586-020-2550-z – volume: 26 start-page: 1636 year: 2020 end-page: 1643 ident: CR7 article-title: An inflammatory cytokine signature predicts COVID-19 severity and survival publication-title: Nat. Med. doi: 10.1038/s41591-020-1051-9 – volume: 3 start-page: 861 year: 2018 ident: CR34 article-title: UMAP: Uniform Manifold Approximation and Projection publication-title: J. Open Source Softw. doi: 10.21105/joss.00861 – volume: 6 start-page: 31 year: 2020 ident: CR18 article-title: Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing publication-title: Cell Discov. doi: 10.1038/s41421-020-0168-9 – volume: 37 start-page: 2322 year: 2019 end-page: 2330 ident: CR30 article-title: IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine publication-title: Vaccine doi: 10.1016/j.vaccine.2019.03.044 – volume: 9 start-page: e01136 year: 2020 ident: CR13 article-title: Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 publication-title: Clin. Transl. Immunol. doi: 10.1002/cti2.1136 – volume: 335 start-page: 984 year: 2012 end-page: 989 ident: CR28 article-title: The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses publication-title: Science doi: 10.1126/science.1215418 – volume: 141 start-page: 1607 year: 2018 end-page: 1619.e9 ident: CR24 article-title: Chronic IL-33 expression predisposes to virus-induced asthma exacerbations by increasing type 2 inflammation and dampening antiviral immunity publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2017.07.051 – volume: 8 start-page: 1233 year: 2020 end-page: 1244 ident: CR10 article-title: Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(20)30404-5 – volume: 21 start-page: 1336 year: 2020 end-page: 1345 ident: CR6 article-title: Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 publication-title: Nat. Immunol. doi: 10.1038/s41590-020-0782-6 – volume: 395 start-page: 497 year: 2020 end-page: 506 ident: CR9 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 – volume: 53 start-page: 1296 year: 2020 end-page: 1314.e9 ident: CR19 article-title: Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 publication-title: Immunity doi: 10.1016/j.immuni.2020.11.017 – volume: 183 start-page: 1508 year: 2020 end-page: 1519.e12 ident: CR15 article-title: Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality publication-title: Cell doi: 10.1016/j.cell.2020.10.052 – volume: 177 start-page: 1888 year: 2019 end-page: 1902.e21 ident: CR32 article-title: Comprehensive integration of single-cell data publication-title: Cell doi: 10.1016/j.cell.2019.05.031 – volume: 26 start-page: 453 year: 2020 end-page: 455 ident: CR16 article-title: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-0819-2 – volume: 20 start-page: 1 year: 2019 end-page: 15 ident: CR33 article-title: Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression publication-title: Genome Biol. doi: 10.1186/s13059-019-1874-1 – ident: CR17 – volume: 42 start-page: 1005 year: 2015 end-page: 1019 ident: CR22 article-title: Interleukin-33 in tissue homeostasis, injury, and inflammation publication-title: Immunity doi: 10.1016/j.immuni.2015.06.006 – volume: 202 start-page: 943 year: 2019 end-page: 955 ident: CR29 article-title: IL-33 augments virus-specific memory T cell inflation and potentiates the efficacy of an attenuated cytomegalovirus-based vaccine publication-title: J. Immunol. doi: 10.4049/jimmunol.1701757 – ident: CR11 – volume: 74 start-page: 1789 year: 2014 end-page: 1800 ident: CR27 article-title: Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-2729 – volume: 84 start-page: 12703 year: 2010 end-page: 12712 ident: CR31 article-title: Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus publication-title: J. Virol. doi: 10.1128/JVI.01182-10 – volume: 587 start-page: 270 year: 2020 end-page: 274 ident: CR4 article-title: SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 publication-title: Nature doi: 10.1038/s41586-020-2598-9 – volume: 358 start-page: 764 year: 1992 end-page: 768 ident: CR21 article-title: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size publication-title: Nature doi: 10.1038/358764a0 – volume: 358 start-page: 764 year: 1992 ident: 22449_CR21 publication-title: Nature doi: 10.1038/358764a0 – volume: 11 year: 2020 ident: 22449_CR2 publication-title: Nat. Commun. doi: 10.1038/s41467-020-18450-4 – volume: 26 start-page: 842 year: 2020 ident: 22449_CR20 publication-title: Nat. Med. doi: 10.1038/s41591-020-0901-9 – volume: 20 year: 2020 ident: 22449_CR23 publication-title: BMC Infect. Dis. doi: 10.1186/s12879-020-05681-5 – volume: 74 start-page: 1789 year: 2014 ident: 22449_CR27 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-2729 – volume: 8 start-page: 1233 year: 2020 ident: 22449_CR10 publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(20)30404-5 – volume: 335 start-page: 984 year: 2012 ident: 22449_CR28 publication-title: Science doi: 10.1126/science.1215418 – volume: 9 start-page: e01136 year: 2020 ident: 22449_CR13 publication-title: Clin. Transl. Immunol. doi: 10.1002/cti2.1136 – volume: 177 start-page: 1888 year: 2019 ident: 22449_CR32 publication-title: Cell doi: 10.1016/j.cell.2019.05.031 – volume: 141 start-page: 1607 year: 2018 ident: 22449_CR24 publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2017.07.051 – volume: 21 start-page: 1336 year: 2020 ident: 22449_CR6 publication-title: Nat. Immunol. doi: 10.1038/s41590-020-0782-6 – ident: 22449_CR11 doi: 10.1126/sciadv.abe3024 – volume: 26 start-page: 1033 year: 2020 ident: 22449_CR12 publication-title: Nat. Med. doi: 10.1038/s41591-020-0913-5 – volume: 584 start-page: 457 year: 2020 ident: 22449_CR5 publication-title: Nature doi: 10.1038/s41586-020-2550-z – volume: 3 start-page: 861 year: 2018 ident: 22449_CR34 publication-title: J. Open Source Softw. doi: 10.21105/joss.00861 – volume: 26 start-page: 1636 year: 2020 ident: 22449_CR7 publication-title: Nat. Med. doi: 10.1038/s41591-020-1051-9 – volume: 587 start-page: 270 year: 2020 ident: 22449_CR4 publication-title: Nature doi: 10.1038/s41586-020-2598-9 – volume: 395 start-page: 497 year: 2020 ident: 22449_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 – volume: 26 start-page: 845 year: 2020 ident: 22449_CR1 publication-title: Nat. Med. doi: 10.1038/s41591-020-0897-1 – volume: 183 start-page: 158 year: 2020 ident: 22449_CR3 publication-title: Cell doi: 10.1016/j.cell.2020.08.017 – volume: 84 start-page: 12703 year: 2010 ident: 22449_CR31 publication-title: J. Virol. doi: 10.1128/JVI.01182-10 – volume: 21 start-page: 245 year: 2020 ident: 22449_CR8 publication-title: Respir. Res. doi: 10.1186/s12931-020-01511-z – volume: 2 start-page: e779 year: 2020 ident: 22449_CR26 publication-title: Lancet Rheumatol. doi: 10.1016/S2665-9913(20)30340-4 – volume: 26 start-page: 453 year: 2020 ident: 22449_CR16 publication-title: Nat. Med. doi: 10.1038/s41591-020-0819-2 – volume: 202 start-page: 943 year: 2019 ident: 22449_CR29 publication-title: J. Immunol. doi: 10.4049/jimmunol.1701757 – volume: 37 start-page: 2322 year: 2019 ident: 22449_CR30 publication-title: Vaccine doi: 10.1016/j.vaccine.2019.03.044 – volume: 183 start-page: 1508 year: 2020 ident: 22449_CR15 publication-title: Cell doi: 10.1016/j.cell.2020.10.052 – volume: 20 start-page: 1 year: 2019 ident: 22449_CR33 publication-title: Genome Biol. doi: 10.1186/s13059-019-1874-1 – volume: 382 start-page: 1708 year: 2020 ident: 22449_CR25 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2002032 – volume: 6 start-page: 31 year: 2020 ident: 22449_CR18 publication-title: Cell Discov. doi: 10.1038/s41421-020-0168-9 – volume: 53 start-page: 1296 year: 2020 ident: 22449_CR19 publication-title: Immunity doi: 10.1016/j.immuni.2020.11.017 – volume: 42 start-page: 1005 year: 2015 ident: 22449_CR22 publication-title: Immunity doi: 10.1016/j.immuni.2015.06.006 – ident: 22449_CR14 doi: 10.1101/2020.12.18.20248331 – ident: 22449_CR17 doi: 10.1126/science.369.6508.1203-l |
| SSID | ssj0000391844 |
| Score | 2.523107 |
| Snippet | Our understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still developing. We perform an observational study to investigate... Our understanding of the immune response to SARS-CoV-2 infection is still incomplete. Here, the authors find that IL-33, produced during immune recall... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2133 |
| SubjectTerms | 13 13/31 38 45 631/250/127/1213 631/326/596/4130 692/308/174 82/80 Adolescent Adult Aged Alveoli Antibodies Antibodies, Viral - immunology Asthma Bronchus CD14 antigen CD4 antigen Cell activation Child Child, Preschool Chronic infection Chronic obstructive pulmonary disease Coronaviruses Correlation COVID-19 COVID-19 - immunology COVID-19 - virology Female Fever Glycoproteins Humanities and Social Sciences Humans IL-1β Immune response Immune system Immunoglobulin G Immunoglobulin G - immunology Immunoglobulin M Infections Interleukin 23 Interleukin 6 Interleukin-33 - immunology Interleukin-33 - metabolism Lung diseases Lymphocytes Lymphocytes T Male Middle Aged Monocytes multidisciplinary Observational studies Pathogenesis Respiratory diseases SARS-CoV-2 - genetics SARS-CoV-2 - immunology SARS-CoV-2 - physiology Science Science (multidisciplinary) Seroepidemiologic Studies Serology Severe acute respiratory syndrome coronavirus 2 Signs and symptoms Spike glycoprotein Spike Glycoprotein, Coronavirus - genetics Spike Glycoprotein, Coronavirus - immunology T-Lymphocytes - immunology T-Lymphocytes - metabolism TLR7 protein Toll-like receptors Tumor necrosis factor Viral diseases Young Adult |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dSxwxEA8iCL6Uftj2Wisp-FaDm012kzzas6JFW9AqvoVsLsED2S3eie1_35lkb_X6-dKnhUt2yc1MMr_fzuwMIdtORRmk8kxFp5hs6po12nBW-ahU4U3DPUZ0Tz7Vh-fy42V1-aDVF-aE5fLAWXC7wAeEUEpXpgwA5idu4oATwCEaYxm1T9VLwec9IFPpDBYGqIvsv5IphN6dyXQmYEYCeC1p2N2SJ0oF-3-HMn9NlvwpYpoc0cFj8qhHkHQvr_wJWQntU7KWe0p-f0bao2MmBA3f-gzXlk5bepMzYQOdd_Rs7_SMjbsLVlKPrTmuEW1SfB9LwRy7nMWFHSXwxvHni6N9xg3F7HTX136i0-ErrtkGOT_48GV8yPqmCswDOJszjd2FoymCE8o3LvgJXAMPAqhL43kdRVV7HDMyFEFz74HwgCwrwIZ1BLDznKy2XRteEipkoQMQkkYYJ31VuXICxycoyYvQ-LIcEb4QsPV9xXFsfHFtU-RbaJuVYkEpNinF3o3Iu-Ger7nexl9nv0e9DTOxVnb6ASzI9hZk_2VBI7K50LrtN_DMAuwD7gRoCf7F22EYth7GU1wbuts0h2NEncOcF9lIhpUk5g_eYETUkvksLXV5pJ1epfLeGoO7Cp65szC0-2X9WRSv_ocoXpP1EncIZiaZTbI6v7kNbwB0zZuttL9-AAvOJX0 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICNxA6tx7MTOCbXbVi3iIVFa7c1yHLusVCVld6vCv--M4021PHqKFNuR4xl7Xp9nCHlrVZBeKsdUsIrJpqpYo2vOSheUyl3dcIcR3c9fqoNj-XFaTpPDbZFglaszMR7Ube_QR74FchiUWRBfxYfznwyrRmF0NZXQuE3uYOoyhHSpqRp9LJj9XEuZ7srkQm8tZDwZEJcAskvW7HJNHsW0_f_SNf-GTP4RN43iaP8BuZ_0SLo9EP4hueW7R-TuUFny92PSHX5iQlD_K-FcOzrr6HzAw3q67OnR9rcjNulPWEEdFug4Q52ToleWAlP2A5YL60rgwMnXk8NdxmuKGHWbMkDR2XiXa_GEHO_vfZ8csFRagTlQ0ZZMY43hUOfeCuUa610LT8-9AAOmcbwKoqwcttXS515z58DsgbUsQUOsAqg8T8lG13f-OaFC5tqDWdKI2kpXlrZo4RAFu8sJ37iiyAhfLbBxKe84lr84MzH-LbQZiGKAKCYSxVxm5N045nzIunFj7x2k29gTM2bHF_381KQNaMCuFEIpXdaFh8m1trVgW4IwDqEI2pUZ2VxR3aRtvDDXTJeRN2MzbECMqtjO9xexD8e4Ooc-zwYmGWcS7X-QCRlRa-yzNtX1lm72Iyb51hjiVfDN9ytGu57W_5fixc1_8ZLcK5D3EXlUb5KN5fzCvwKlatm8jjvnCrdYHbI priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA-1Ivgi9fv6IRF80-Bmk90kj3VracUPsLb0LWRziR6U3XJ3pe1_70z2Q07bgk8Hl8kxl5nZmdmZ_IaQN05FGaTyTEWnmKzLktXacFb4qFTmTc09VnS_fC0PjuWn0-J0jeTDXZjUtJ8gLdNjeugOe7-QyaSxoQCcjjTs8h65j9DtqNVVWY3vVRDxXEvZ34_JhL5h64oPSlD9N8WX_7ZJ_lUrTS5of4M86mNHuttx-5isheYJedBNk7x-SprDz0wIGq763taGzho673pgA1229Gj3-xGr2hOWU49DOc4wzqT4JpaCIrZd_xbOksCN1beTwz3GDcW-dNejPtHZeH9r8Ywc73_8UR2wfpwC8xCWLZnGucLRZMEJ5WsX_BQ-Aw8Ckpba8zKKovS4ZmTIgubeQ6oDZ1lAVFhGCHOek_WmbcJLQoXMdIBUpBbGSV8ULp_CgxNyLS9C7fN8QvhwwNb3WOM48uLMppq30LYTigWh2CQUezkhb8c95x3Sxp3UH1BuIyWiZKcv2vlP22uNhVxSCKV0YfIAzE3d1EE-CQ44xjxqX0zI9iB125vuwkLAB1kTxEnwL16Py2B0WElxTWgvEg3HWjoHmhedkoycpJwf_MCEqBX1WWF1daWZ_UrA3hrLugp-892gaH_Yuv0oNv-PfIs8zNEWsPvIbJP15fwi7EBgtaxfJUv6DdamHA4 priority: 102 providerName: Springer Nature |
| Title | IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals |
| URI | https://link.springer.com/article/10.1038/s41467-021-22449-w https://www.ncbi.nlm.nih.gov/pubmed/33837219 https://www.proquest.com/docview/2510491902 https://www.proquest.com/docview/2511242112 https://pubmed.ncbi.nlm.nih.gov/PMC8035172 https://doaj.org/article/89933778592e495dada140299ff2f8c5 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELf2IdBeEN8URmUk3sDQxE4cPyDUhZWtYgOtdOqb5bgOVKoSaDtt---5cz6g0PHSSLFdXXx3ufvlzneEvDQyF05Iy2RuJBNZHLMsUQGLbC5lz6ossBjRPTmNj8ZiOIkmW6Rpd1Rv4HIjtMN-UuPF_M3Vz-v3oPDvqiPjydul8OqOyQZgkIRil9tkFyyTREU9qd19_2bmCgCNqM_ObF66R2571BZi7Z0_TJWv6L_JDf03m_KvkKq3VIO75E7tYtJ-JRP3yJYr7pNbVdPJ6wekOP7EOKfuqk6BLeisoIsqVdbRVUlH_bMRS8tzFlKLvTvm6I5S_GBLQV7LKs0LW07gwvTz-fEHFiiK6eumLg5FZ-0xr-VDMh4cfk2PWN11gVnw3lYswfbDueo5w6XNjLNTuLrAccA2mQ3inEexxTElXM8lgbWAiGBbI3Ae4xy8oUdkpygL94RQLnqJA8SScWWEjSITTuH9CpDMcpfZMOyQoNlgbeuS5NgZY659aJwnuuKPBv5ozx992SGv2jU_qoIc_519gHxrZ2IxbX-jXHzTtW5qgJycS5lEKnRA3NRMDcBOsNN5HuaJjTpkv-G6bgRUg18I4ArcKXiKF-0w6CYGXEzhygs_J8CQewBzHldC0lLSCFmHyDXxWSN1faSYfff1vxOM_kr4z9eNoP0m6-ateHojCc_IXogagPlIap_srBYX7jm4WqusS7blRMJvMvjYJbv9_nA0hOvB4emXM7ibxmnXf8Toej37Bf2ZJ88 |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGEIIXxJ3AACPBE1hLbCdOHhAaHVPLuiGxi_pmHMeBSlMy2k5lf4rfyDnOZSqXve2pUu1Ejs_d5_h8hLwyqpROKstUaRSTeZKwPM0iFttSqdBmeWQxo7u3nwyP5KdJPFkjv7q7MFhW2elEr6iL2uIZ-SbYYXBmwXzx96c_GKJGYXa1g9Bo2GLXnS8hZJu_G20DfV9zvvPxcDBkLaoAs-CdLFiK8LplFjojlM2NswX8usgJ8N1zGyWliBOLY5l0oUsja8HjhzgoBucoKcHaw3uvketgeEOUKDVR_ZkOdltPpWzv5oQi3ZxLr4mwDgJspczYcsX-eZiAf_m2f5do_pGn9eZv5w653fqtdKthtLtkzVX3yI0GyfL8PqlGYyYEdT_butqKTis6a-pvHV3U9GDrywEb1MeMU4uAICfo41I8BaYgBHVTO4Y4Fvjg4PPxaJtFGcWaeNN2nKLT_u7Y_AE5upJNf0jWq7pyjwkVMkwdhEG5yIy0cWx4AUob4jwrXG45D0jUbbC2bZ9zhNs40T7fLlLdEEUDUbQnil4G5E3_zGnT5ePS2R-Qbv1M7NDt_6hn33Qr8BriWCGUSuOMO1hcYQoDsSwY_7LkZWrjgGx0VNet2pjrCyYPyMt-GAQeszimcvWZnxNhHj-COY8aJulX4s8bwAYFRK2wz8pSV0eq6XffVDzFlLKCd77tGO1iWf_fiieXf8ULcnN4uDfW49H-7lNyi6McYNVTtkHWF7Mz9wwcukX-3EsRJV-vWmx_A8LRWfc |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEIgXxDcZA4wET2C1sZ04eUBotFQrGwMxNvXNcxyHVZqS0XYq-9f467hzPqbysbc9VaqdyPF9_c53viPkpVGFdFJZpgqjmMzimGVJGrLIFkr1bZqFFiO6n_bi7QP5cRJN1siv9i4MplW2OtEr6ryyeEbeAzsMYBbMF-8VTVrEl-Ho3ekPhh2kMNLattOoWWTHnS_BfZu_HQ-B1q84H334NthmTYcBZgGpLFiCrXaLtO-MUDYzzubw60InAMdnNowLEcUWx1Lp-i4JrQX0Dz5RBEApLsDyw3uvketKRCHKmJqo7nwHK68nUjb3dPoi6c2l10qYEwF2U6ZsuWILfcuAf-Hcv9M1_4jZelM4ukNuNxiWbtVMd5esufIeuVF3tTy_T8rxLhOCup9Njm1JpyWd1bm4ji4qur_1dZ8NqkPGqcXmICeIdymeCFMQiKrOI8OeFvjg4PPheMjClGJ-vGmqT9Fpd49s_oAcXMmmPyTrZVW6x4QK2U8cuESZSI20UWR4DgocfD4rXGY5D0jYbrC2Tc1zbL1xon3sXSS6JooGomhPFL0MyOvumdO64sels98j3bqZWK3b_1HNvutG-DX4tEIolUQpd7C43OQG_FoAAkXBi8RGAdlsqa4bFTLXFwwfkBfdMAg_RnRM6aozPyfEmH4Icx7VTNKtxJ89gD0KiFphn5Wlro6U02NfYDzB8LKCd75pGe1iWf_fio3Lv-I5uQkCq3fHeztPyC2OYoAJUOkmWV_MztxTwHaL7JkXIkqOrlpqfwMVSV4t |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-33+expression+in+response+to+SARS-CoV-2+correlates+with+seropositivity+in+COVID-19+convalescent+individuals&rft.jtitle=Nature+communications&rft.au=Stanczak%2C+Michal+A&rft.au=Sanin%2C+David+E&rft.au=Apostolova%2C+Petya&rft.au=Nerz%2C+Gabriele&rft.date=2021-04-09&rft.eissn=2041-1723&rft.volume=12&rft.issue=1&rft.spage=2133&rft_id=info:doi/10.1038%2Fs41467-021-22449-w&rft_id=info%3Apmid%2F33837219&rft.externalDocID=33837219 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |